New Stock Preview | Embracing Biotechnology: Revenue of nearly 1.8 billion yuan but still incurring losses. Zhu Zhongyuan's dual perspective on the 'capital bureau'.
Eme Biotech, which is currently insolvent, has only one way to go: seek listing on the Hong Kong Stock Exchange.
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $171
CCORF analyst John Newman maintains $BioNTech(BNTX.US)$ with a buy rating, and maintains the target price at $171.According to TipRanks data, the analyst has a success rate of 38.6% and a total
Promising BNT327 Data Bolsters BioNTech's Buy Rating, With a Target of $171
US stocks | Included in the s&p 500 index! AI stock Palantir soared more than 14% overnight; New drug efficacy beats merck! Biopharmaceutical company SMMT surged 56% in response.
The medical devices giants hit a new record high, with Boston Scientific up 1.29% overnight; Mastercard rose 2.3% overnight, reaching another all-time high.
Why Is Moderna Stock Trading Higher On Monday?